U.S. Oligonucleotide Synthesis Market Size & Outlook
U.S. oligonucleotide synthesis market, 2018-2030 (US$M)
Related Markets
U.S. oligonucleotide synthesis market highlights
- The U.S. oligonucleotide synthesis market generated a revenue of USD 1,500.2 million in 2024 and is expected to reach USD 3,090.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 12.8% from 2025 to 2030.
- In terms of segment, services was the largest revenue generating segment in 2024.
- Services is the most lucrative segment segment registering the fastest growth during the forecast period.
Oligonucleotide synthesis market data book summary
| Market revenue in 2024 | USD 1,500.2 million |
| Market revenue in 2030 | USD 3,090.0 million |
| Growth rate | 12.8% (CAGR from 2024 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.0% of the global oligonucleotide synthesis market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. oligonucleotide synthesis market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 306.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oligonucleotide Synthesis Market Scope
Oligonucleotide Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. oligonucleotide synthesis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide synthesis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 37.67% in 2024. Horizon Databook has segmented the U.S. oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. oligonucleotide synthesis market has witnessed significant growth in recent years. Growth in the region can be attributed to the increasing demand for synthetic DNA & RNA sequences in various applications, such as research, diagnostics, and therapeutics.
. The competitive landscape of this market is characterized by a mix of established players and emerging companies striving to capture a share of the expanding market. Moreover, Integrated DNA Technologies, Thermo Fisher Scientific, Eurofins Scientific, and Bio-Synthesis, Inc. are some of the leading players in the oligonucleotide synthesis market, known for their comprehensive portfolio of high-quality products and services.
Reasons to subscribe to U.S. oligonucleotide synthesis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. oligonucleotide synthesis market databook
-
Our clientele includes a mix of oligonucleotide synthesis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. oligonucleotide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into U.S. oligonucleotide synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. oligonucleotide synthesis market size, by segment, 2018-2030 (US$M)
U.S. Oligonucleotide Synthesis Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
